<VariationArchive VariationID="430724" VariationName="NM_001320.7(CSNK2B):c.108dup (p.Thr37fs)" VariationType="Duplication" Accession="VCV000430724" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-10" DateCreated="2017-07-17" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="424262" VariationID="430724">
      <GeneList>
        <Gene Symbol="CSNK2B" FullName="casein kinase 2 beta" GeneID="1460" HGNC_ID="HGNC:2460" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="31666080" stop="31670067" display_start="31666080" display_stop="31670067" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_113891.3" start="3143371" stop="3147358" display_start="3143371" display_stop="3147358" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167245.2" start="2913852" stop="2917839" display_start="2913852" display_stop="2917839" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167246.2" start="2971127" stop="2975114" display_start="2971127" display_stop="2975114" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167247.2" start="3007952" stop="3011939" display_start="3007952" display_stop="3011939" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167248.2" start="2921904" stop="2925891" display_start="2921904" display_stop="2925891" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167249.2" start="2965364" stop="2969351" display_start="2965364" display_stop="2969351" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="31633656" stop="31637842" display_start="31633656" display_stop="31637842" Strand="+" />
          </Location>
          <OMIM>115441</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001320.7(CSNK2B):c.108dup (p.Thr37fs)</Name>
      <CanonicalSPDI>NC_000006.12:31667901:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6p21.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="31667901" stop="31667902" display_start="31667901" display_stop="31667902" variantLength="1" positionVCF="31667901" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="31635678" stop="31635679" display_start="31635678" display_stop="31635679" variantLength="1" positionVCF="31635678" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <OtherNameList>
        <Name>CSNK2B</Name>
        <Name>1-BUP DUP, NT108</Name>
      </OtherNameList>
      <ProteinChange>T37fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.31635680dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.31635680dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.31667903dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.31667903dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282385.2" sequenceAccession="NM_001282385" sequenceVersion="2" change="c.108dup">
            <Expression>NM_001282385.2:c.108dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269314.1" sequenceAccession="NP_001269314" sequenceVersion="1" change="p.Thr37fs">
            <Expression>NP_001269314.1:p.Thr37fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320.7" sequenceAccession="NM_001320" sequenceVersion="7" change="c.108dup" MANESelect="true">
            <Expression>NM_001320.7:c.108dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001311.3" sequenceAccession="NP_001311" sequenceVersion="3" change="p.Thr37fs">
            <Expression>NP_001311.3:p.Thr37fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645372425" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="115441.0003" DB="OMIM" />
        <XRef Type="rs" ID="1131692161" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="loss_of_function_variant">
        <XRef ID="SO:0002054" DB="Sequence Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001320.7(CSNK2B):c.108dup (p.Thr37fs) AND Intellectual disability and seizures" Accession="RCV000495848" Version="1">
        <ClassifiedConditionList TraitSetID="21809">
          <ClassifiedCondition DB="MedGen" ID="CN231403">Intellectual disability and seizures</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-06-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001320.7(CSNK2B):c.108dup (p.Thr37fs) AND Poirier-Bienvenu neurodevelopmental syndrome" Accession="RCV000993566" Version="2">
        <ClassifiedConditionList TraitSetID="52018">
          <ClassifiedCondition DB="MedGen" ID="C5231482">Poirier-Bienvenu neurodevelopmental syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-02-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-07-17" MostRecentSubmission="2024-06-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28762608</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="52018" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43281" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Poirier-Bienvenu neurodevelopmental syndrome</ElementValue>
                <XRef ID="MONDO:0032889" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">POBINDS</ElementValue>
                <XRef Type="MIM" ID="618732" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">CSNK2B-Related Neurodevelopmental Disorder</Attribute>
              </AttributeSet>
              <XRef ID="C5231482" DB="MedGen" />
              <XRef ID="MONDO:0032889" DB="MONDO" />
              <XRef Type="MIM" ID="618732" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="21809" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33566" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability and seizures</ElementValue>
              </Name>
              <XRef ID="CN231403" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1138443" SubmissionDate="2017-07-07" DateLastUpdated="2017-07-17" DateCreated="2017-07-17">
        <ClinVarSubmissionID localKey="SUB2844537" submittedAssembly="GRCh37" title="SUB2844537" />
        <ClinVarAccession Accession="SCV000583466" DateUpdated="2017-07-17" DateCreated="2017-07-17" Type="SCV" Version="1" SubmitterName="Center for Medical Genetics, Keio University School of Medicine" OrgID="506260" OrganizationCategory="laboratory" OrgAbbreviation="CMG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A de novo frameshift mutation. The gene, CSNK2B, has been listed as a loss-of-function intolerant gene. "CSNK2B splice site mutations in patients cause intellectual disability with or withoutmyoclonic epilepsy" (DOI: 10.1002/humu.23270) Splice site mutations in CSNK2B has recently been reported as a cause of intellectual disability with or without myoclonic epilepsy.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Sporadic</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Ethnicity>Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Paired-end mapping</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001320.6:exon 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">CSNK2B_001</Name>
            <Name>CSNK2B</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="115441" />
          </XRefList>
          <FunctionalConsequence Value="loss_of_function_variant" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_001320.6:c.108dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN231403" />
          </Trait>
        </TraitSet>
        <StudyName>IRUD at Keio</StudyName>
        <StudyDescription>Initiative on Rare and Undiagnosed Diseases</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB2844537</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2258429" SubmissionDate="2020-01-15" DateLastUpdated="2024-06-09" DateCreated="2020-01-19">
        <ClinVarSubmissionID localKey="115441.0003_POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME" title="CSNK2B, 1-BP DUP, NT108_POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME" />
        <ClinVarAccession Accession="SCV001146668" DateUpdated="2024-06-09" DateCreated="2020-01-19" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 21-month-old Japanese boy with Poirier-Bienvenu neurodevelopmental syndrome (POBINDS; 618732), Sakaguchi et al. (2017) identified a de novo heterozygous 1-bp duplication (c.108dup, NM_001320.6) in exon 3 of the CSNK2B gene, predicted to result in a frameshift and premature termination (Thr37Tyrfs). The mutation was found by trio-based whole-exome sequencing and confirmed by Sanger sequencing. Functional studies of the variant and studies of patient cells were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">28762608</ID>
              </Citation>
              <XRef DB="OMIM" ID="618732" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CSNK2B" />
          </GeneList>
          <Name>CSNK2B, 1-BP DUP, NT108</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, NT108</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="115441.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2258429" TraitType="Disease" MappingType="Name" MappingValue="POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C5231482" Name="Poirier-Bienvenu neurodevelopmental syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1138443" TraitType="Disease" MappingType="XRef" MappingValue="CN231403" MappingRef="MedGen">
        <MedGen CUI="CN231403" Name="Intellectual disability and seizures" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

